Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study.

Journal of cancer research and therapeutics(2023)

引用 0|浏览7
暂无评分
摘要
R-CHOP and DA-EPOCH-R showed good results in PMBL. These remain one of the best determined systemic treatment options for first-line therapy. Also, the treatment was associated with good efficacy and tolerability.
更多
查看译文
关键词
lymphoma patients,turkısh oncology group study,treatment options
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要